The diabetogenic agent streptozotocin (STZ) [1±5] is a d-glucopyranose derivative of N-methyl-N-nitrosourea (MNU). Both STZ and MNU are potent alkylating agents [6] , highly toxic and carcinogenic [3, 7] but only STZ is diabetogenic because of the selective destruction of the insulin-producing beta cells resulting from necrosis [8, 9] . It has been suggested that the selective beta-cell toxicity of STZ is related to the glucose moiety in its chemical structure which enables STZ to enter the beta cell via the low affinity glucose transporter GLUT2 in the plasma membrane [4] . This hypothesis is supported by the observation that the RINm5F rat insulinoma cell line, which does not express this glucose transporter, resists STZ toxicity [10, 11] and becomes sensitive to the toxic action of this compound only after expression of the GLUT2 glucose transporter in this cell line [12] . This observation could explain the greater toxicity of STZ when compared with MNU in GLUT2-express- Diabetologia (2000) Methods. GLUT2 expressing RINm5F cells were generated through stable transfection of the rat glucose transporter GLUT2 cDNA under the control of the cytomegalovirus promoter in the pcDNA3 vector. Viability of the cells was determined using a microtitre plate-based 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay.
ing beta cells even though both substances alkylate DNA to a similar extent [13, 14] .
Although the exact mechanism of the diabetogenic action of STZ has not been elucidated, it has generally been assumed that its toxic action relates to the DNA alkylating activity of its MNU moiety [6, 14±16] , especially at the O 6 position of guanine [17±19] . Damage to DNA by STZ apparently depletes NAD + , which in turn inhibits insulin biosynthesis and secretion and leads finally to beta-cell death through ATP depletion [15, 20, 21] .
This concept has been convincingly confirmed recently by the observation that mice deficient in poly (ADP-ribose) polymerase (PARP) are resistant to beta-cell death mediated by STZ in spite of DNA fragmentation. The absence of PARP, which is activated by DNA damage, prevents the depletion of its cofactor NAD + and subsequent loss of ATP [22±25] . An alternative hypothesis proposes that some of the diabetogenic properties of STZ could relate not to its alkylating ability but to its potential to act as a nitric oxide donor [26] . Both STZ and MNU contain a nitroso group and could liberate nitric oxide [16, 27±31] in a manner similar to that of other nitric oxide donors such as sodium nitroprusside or 3-morpholinosydnonimine (SIN-1) [32] . To investigate the potential role of nitric oxide in the action of STZ and other nitrosoureas, we included the alkylating agent methyl methanesulphonate (MMS) which is not a nitric oxide donor [33] .
The role of alkylation in beta-cell death could be further examined by the use of the ethylating agents N-ethyl-N-nitrosourea (ENU) and ethyl methanesulphonate (EMS). These ethylating agents are less toxic than their methylating counterparts [19, 33] . This has been attributed to O 6 -ethylguanine being 10 to 100 times less toxic than O 6 -methylguanine [19] . A lower toxicity of the ethylating agents could be evidence of a role for O 6 -alkylguanine in the mechanism of the toxic action of this group of alkylating compounds.
Thus STZ and the four other chemically related alkylating compounds, which, unlike STZ are not diabetogenic, are test agents with different chemical properties [33] , which could help explain the mechanism responsible for the selective beta-cytotoxic action and subsequent diabetogenicity of STZ.
We therefore compared the toxicity of these five test compounds (Fig. 1 ) using the MTT cytotoxicity assay, in control RINm5F insulin-producing tissue culture cells and in RINm5F cell clones overexpressing glucokinase or GLUT2. Both structures serve as main low-affinity-signal recognition entities for glucose-induced insulin secretion in beta cells and as such could be involved in mediating the toxicity of STZ.
Materials and methods
Materials. Streptozotocin was obtained from Alexis (San Diego, Calif., USA), MNU, MMS and EMS from Sigma (St. Louis, Mo., USA) and ENU from Serva (Heidelberg, Germany).
The cDNA coding for rat human beta-cell glucokinase was kindly provided by A. Permutt (St. Louis, Mo., USA), the cDNA of the rat GLUT2 and the anti-GLUT2 antibody by B. Thorens (Lausanne, Switzerland). The glucokinase antibody was generated in rabbits against rat recombinant liver glucokinase [34] .
Restriction enzymes, the SP6/T7 transcription kit and the DIG nucleic acid detection kit were obtained from Boehringer (Mannheim, Germany). Immobilon-P polyvinylidene difluoride (PVDF) membranes were from Millipore (Bedford, Mass., USA). Peroxidase-labelled anti-rabbit-IgG antibody and BCA assay reagent were from Sigma (St. Louis, Mo., USA). Hybond N nylon membranes, the electrogenerated chemiluminescence (ECL) detection system, autoradiography films and 3-O-methyl [1- 3 H]glucose were from Amersham (Braunschweig, Germany).
Geneticin (G 418), lipofectamine and all other tissue culture equipment were from Gibco BRL (Gaithersburg, Md., USA). Guanidine thiocyanate was from Fluka (Neu-Ulm, Germany). All other reagents of analytical grade were from Merck (Darmstadt, Germany). 
D E
Tissue culture and viability tests. The RINm5F insulin-producing tissue culture cells (passage 55±70) were cultured in RPMI 1640 medium, supplemented with 10 mmol/l glucose, 10 % (v/ v) foetal calf serum, penicillin and streptomycin in a humidified atmosphere at 37 C and 5 % CO 2 [35] . Control and transfected RINm5F cells were seeded at a concentration of 2´10 4 cells/well in 100 ml culture medium in 96-well microplates, and incubated at 37 C with the test compounds. All test compounds were dissolved in 10 mmol/l HCl immediately before the experiment and added to HEPES (20 mmol/l) supplemented KRB medium without glucose for 1 h. The buffer was then removed and the cells were incubated for another 18 h in RPMI 1640 medium. After the incubation period, the viability of the cells was determined using a microtitre-plate-based MTT assay [36] and expressed as a percentage of the untreated samples. Unless otherwise indicated experiments were done in HEPES (20 mmol/l) buffered Krebs-Ringer bicarbonate medium (pH 7.4) [37] . Glucokinase enzyme activities of RINm5F-GK cells were measured according to a previous study [34] . The glucose transport of RINm5F cells was quantified as described previously [38] . The DNA content of RINm5F cells was measured according to a previous study [39] .
Stable overexpression in RINm5F cells. The GLUT2-expressing RINm5F cells were generated through stable transfection of the rat GLUT2 cDNA [40] under the control of cytomegalovirus promoter in the pcDNA3 vector using lipofectamine [35] . Overexpression of glucokinase in RINm5F cells was done in an analogous manner resulting in a tenfold higher enzyme activity [34] . Transfected clones were selected through resistance against G418.
Northern blot analyses. The RINm5F cells were homogenised in buffered 4 mol/l guanidine thiocyanate solution. Total RNA was isolated according to methods described previously [41] . 10 mg of RNA per lane were separated through electrophoresis on denaturing formamide/formaldehyde 1 % agarose gels and transferred to nylon membranes. We hybridised RNA using digoxigenin(DIG)-labelled antisense cRNA probes coding for rat GLUT2 [40] . The DIG-labelled hybrids were detected by an enzyme-linked immunoassay followed by chemiluminescence. The intensity of the bands was quantified through densitometry with the National Institutes of Health (NIH) Image 1.58 program (Bethesda, Md., USA).
Western blot analyses. The RINm5F cells were homogenised in Krebs-Ringer buffer by sonication on ice (60 W, 3 bursts of 10 s). Microsomal protein was prepared according to a previous study [42] . Protein was quantified by a bicinchoninic acid (BCA) assay with bovine albumin as standard. A total of 30 mg RINm5F cell protein or microsomal protein were fractionated by reducing 10 % sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis and electroblotted to PVDF membranes. The membranes were stained by Ponceau to verify the transfer of comparable amounts of cellular protein. Non-specific binding sites of the membranes were blocked overnight by non-fat dry milk at 4 C. Thereafter the blots were incubated with specific primary antibody against rat GLUT2, at a dilution of 1:10 000 overnight at 4 C, followed by a 2-hour incubation with peroxidase-labelled secondary antibody at a dilution of 1:15 000 at room temperature. The protein bands were visualised by electrogenerated chemiluminescence (ECL).
Statistical analyses. Data are expressed as means SEM. Statistical analyses were done using one-way ANOVA followed by Dunnett's test for multiple comparisons. The EC 50 was calculated from non-linear regression analysis using least square algorithms of the Prism analysis program (Graphpad, San Diego, Calif., USA).
Results
The RINm5F insulin-producing tissue culture cells which do not express the low affinity GLUT2 (Fig. 2) were extraordinarily resistant to the toxic effect of STZ (Fig. 3) . The half maximally effective concentration (EC 50 ) of STZ, at which 50 % of the cells had lost their viability in the MTT cytotoxicity assay, was 25 mmol/l (Table 1) . After transfection of the RINm5F cells with the GLUT2 (Fig. 2), both clones (A and B) expressing RINm5F cells were transfected with human beta cell glucokinase cDNA or rat GLUT2 cDNA. Clones expressing GLUT2 were characterised by Western and Northern blot analyses for protein and mRNA expression, respectively. RNA (10 mg) was hybridised with an antisense cRNA probe coding for rat GLUT2, protein (30 mg) was analysed using an antibody against rat GLUT2. Representative blots are from 4 separate experiments. Control and glucokinase overexpressing RINm5F cells did not express the GLUT2. When compared with rat liver (100 %) the GLUT2 mRNA expression was 140 25 % in clone A and 81 8 % in clone B; the GLUT2 protein expression was 183 23 % in clone A and 61 17 % in clone B.
this glucose transporter were sensitive to the toxic action of STZ as shown by the concentration-dependent loss of cell viability in the MTT assay (Fig. 3) .
In both clones, the expression of the GLUT2 was in the range of that in the liver (Fig. 3) . Clone A, which had a higher mRNA and protein expression, was more susceptible to STZ toxicity than clone B (Fig. 3) , as confirmed by the difference in the half maximally effective concentration (EC 50 ) of STZ in the MTT assay (2.1 vs 3.9 mmol/l) (Fig. 3, Table 1 ).
At variance from the situation in the clones expressing the GLUT2, no increase in susceptibility to STZ was observed in the clone overexpressing glucokinase (Fig. 3) and the EC 50 of STZ was not significantly different from that of the control cells (Table 1) . This was confirmed in a control experiment in which glucokinase was overexpressed in a RINm5F cell clone with constitutive GLUT2 expression [43] where the susceptibility towards STZ toxicity in the MTT assay was also unchanged (unpublished data).
The aglycone of STZ, MNU, was as toxic to control RINm5F cells as to those expressing the GLUT2 or glucokinase. The EC 50 was in the range of the values obtained for STZ in the GLUT2 expressing cell clones (Table 1 ). There was, however, no significant difference in the EC 50 values for control and transfected cells ( Table 1 ), proving that it is the glucose moiety that allows the selectivity in the toxic action of STZ. Although STZ uses the low affinity GLUT2 to enter the cell, it does not disturb its function, as is shown by the lack of effect on 3-O-methyl [1] [2] [3] H]glucose uptake into GLUT2 expressing RINm5F cells (A-clone, Fig. 4 ; B-clone, data not shown).
The MMS was also toxic to RINm5F cells, again without showing any selectivity in its toxicity. In par- Data are means SEM. Numbers of experiments given in parentheses. Cells were exposed to serial concentrations of the test compounds as used in the concentration dependencies shown in Fig. 1 . Viability of the cells was determined by the MTT assay. The EC 50 values were calculated by non-linear regression analyses. *p < 0.01 compared with non-transfected control RINm5F cells ticular this applied to the GLUT2-expressing RINm5F-cell clones which were no more sensitive to the toxic action of MMS than the control cells or glucokinase overexpressing cells (Table 1 ). Since MMS, unlike MNU, does not generate nitric oxide during decomposition (Fig. 1) this indicates that nitric oxide is not required for the toxic action of this group of alkylating agents including the diabetogenic compound STZ.
Both ENU and EMS were significantly less toxic to RINm5F cells than MNU and MMS, as shown by the significantly higher EC 50 values in the MTT cytotoxicity assay (Table 1) . This supports the contention that in these RINm5F insulin-producing cells, as in other cell types, the mechanism of toxic action is due to alkylation [6] , with the methylation of DNA bases being more toxic than the ethylation [19] . Again, the ethyl derivatives were not selectively toxic (Table 1) .
Discussion
Our results, together with previous observations mentioned above, explain the mechanism of the beta-cell toxic and diabetogenic action of STZ as follows:
1. The toxic action of STZ and chemically related alkylating compounds requires their uptake into the cells (Fig. 3) . 2. STZ causes beta-cell death and is diabetogenic because it is taken up selectively by beta cells through the low affinity glucose transporter GLUT2 [12] . 3. The glucose moiety in the structure of the molecule (Fig. 1 ) enables STZ to be transported into the beta cell through this specific glucose transporter. 4. In insulin-producing cells not expressing the GLUT2, the cellular uptake of STZ is very slow. Correspondingly low is the toxicity (Fig. 3) . 5. The importance of the GLUT2 is also confirmed by the observation of STZ damage to other cells expressing this transporter such as hepatocytes and renal tubular cells [40] . Thus any STZ treatment of animals leads not only to diabetes but also to liver and kidney damage [1] . 6. Glucokinase, the low affinity glucose phosphorylating enzyme and glucose sensor of the beta cell, which, in concert with the GLUT2, is responsible for generating the metabolic signal for glucose-induced insulin secretion [43] is not actively involved in mediating the toxic action of STZ. The expression level of glucokinase is thus not important, at variance from the GLUT2. In particular there seems to be no critical interaction between these low affinity glucose recognition structures in mediating the beta-cell toxicity of STZ. 7. Toxicity of STZ and related agents resides in their ability to alkylate DNA [6] . Such DNA damage causes, along a defined chain of events [25] , necrosis of beta cells [9] . The concomitant activation of poly (ADP-ribose) polymerase (PARP) depletes NAD + and subsequently also ATP by overstimulation of the DNA repair mechanisms [25] .
As STZ is the glycone of MNU, a member of the chemical group of the nitrosoureas which for decades have been used due to their DNA toxicity as anti-cancer drugs, it is not surprising that the cytotoxic activity of STZ originates from the nitrosomethylurea moiety in its chemical structure. 8. Nitric oxide generation is apparently not a prerequisite for the toxic action of all compounds of this group. This is supported by the observation that MMS which does not generate nitric oxide [33] is more toxic than the nitrosoureas MNU and ENU (Table 1 ).
In conclusion, it is possible to explain the mechanism underlying the necrotic beta-cell destruction in STZ diabetes, as a result of selective uptake of the compound through the low affinity GLUT2 into the beta cell and subsequent destruction through DNA damage. In chemical terms it is the glucose molecule in the structure which gives way to selective uptake of STZ into the beta cell, while the MNU nitrosourea moiety of STZ allows for its activity as an alkylating agent.
